NexImmune to lay off over half of its employees
NexImmune will reduce its workforce from 47 to just 22 full-time employees and has also paused enrolment for three of its trials.
NexImmune will reduce its workforce from 47 to just 22 full-time employees and has also paused enrolment for three of its trials.
What's Your Reaction?
